FULC — Fulcrum Therapeutics Share News
0.000.00%
Last trade - 00:00- $280.77m
- -$38.07m
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback
Fulcrum Therapeutics rises on all-stock merger with Slate Medicines
Fulcrum Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns (updated)
U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems
U.S. STOCKS ON THE MOVE-Microchip Technology, Marvell Technology, Generac
Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns
Fulcrum falls after discontinuing sickle cell drug program
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development